CATHERINE HEALY to Middle Aged
This is a "connection" page, showing publications CATHERINE HEALY has written about Middle Aged.
Connection Strength
0.286
-
Knowledge and attitiudes of pregnant women and their providers towards recommendations for immunization during pregnancy. Vaccine. 2015 Oct 05; 33(41):5445-5451.
Score: 0.031
-
Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center. Vaccine. 2015 Sep 11; 33(38):4983-7.
Score: 0.031
-
Acceptability of immunization in adult contacts of infants: possibility of expanding platforms to increase adult vaccine uptake. Vaccine. 2014 May 07; 32(22):2540-5.
Score: 0.028
-
Parent and provider perspectives on immunization: are providers overestimating parental concerns? Vaccine. 2014 Jan 23; 32(5):579-84.
Score: 0.027
-
Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother. 2013 Sep; 9(9):1926-31.
Score: 0.027
-
Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011 Jan 15; 52(2):157-62.
Score: 0.022
-
Pertussis immunization in a high-risk postpartum population. Vaccine. 2009 Sep 18; 27(41):5599-602.
Score: 0.020
-
The cocoon strategy. Tex Med. 2008 Aug; 104(8):3.
Score: 0.019
-
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials. JAMA Netw Open. 2025 May 01; 8(5):e2512763.
Score: 0.015
-
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials. JAMA Netw Open. 2024 05 01; 7(5):e2412835.
Score: 0.014
-
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. 2023 07 03; 6(7):e2323349.
Score: 0.013
-
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N Engl J Med. 2022 Feb 10; 386(6):531-543.
Score: 0.012
-
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med. 2021 Nov 04; 385(19):1774-1785.
Score: 0.012
-
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 02 04; 384(5):403-416.
Score: 0.011
-
Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 2003 Dec; 4(8):533-40.
Score: 0.003